SCHEMBL2640795

SCHEMBL2640795

CCC1CCCCN1c1ccnc(Cl)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HIF1A Q16665 1/20 0.42
NOS2 P35228 11/20 0.40
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
SYK P43405 1/20 0.39
NPY5R Q15761 1/20 0.38
KDM4E B2RXH2 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MTOR P42345 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12185048 0.81 BCHE (0.43) MAPTALDH1A1SYKKDM4ELMNA
SCHEMBL12615103 0.81 BCHE (0.43) MAPTALDH1A1SYKKDM4ELMNA
SCHEMBL7905968 0.76 CHRNB1 (0.43)
SCHEMBL12486555 0.75 MAPT (0.40) HPGDMAPTALDH1A1HIF1APSEN1
SCHEMBL4580268 0.74 NUDT1 (0.46) HPGDMAPTALDH1A1PSEN1PSEN2
SCHEMBL83400 0.73 CUL4A (0.38) HPGDMAPTALDH1A1HIF1APSEN1
SCHEMBL16792885 0.73 MAPT (0.40) HPGDMAPTALDH1A1HIF1APSEN1
SCHEMBL9893169 0.71 FFAR1 (0.46) ALDH1A1PSEN1PSEN2APH1BNCSTN
SCHEMBL1331448 0.71 METAP2 (0.62) NOS2
SCHEMBL1331859 0.71 METAP2 (0.62) NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2600874-A1 PYRIMIDINE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE Amgen, Inc (US) 2013-06-12 EP disclosed
WO-2011143033-A1 PYRIMIDINE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2011-11-17 WO disclosed